News from the fight to
#SaveIndependentPharmacy
New York Times The Middlemen series
CVS hellth: Corporate consolidation is ruining pharmacies and hurting patients
An opinion piece by pharmacist and independent pharmacy advocate Luke Slindee.
‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits
A STAT News Investigation
Commerce fines CVS Caremark $500,000 after 2022 case alleging violations of Pharmacy Benefit Manager Act
The Minnesota Department of Commerce announced it has levied a $500,000 penalty against the pharmacy benefit manager CVS Caremark after alleging that Caremark violated state law prohibiting a practice known as ‘patient steering.’
HMO profits from Minnesota state programs jump to $675.8M with enrollment surge
Enrollees used less care than expected, and a state program to cap profits was no longer in place, leading to an increase of about 181% in operating income.
NY Governor Hochul Launches New Statewide Medicaid Pharmacy Benefit Program
Long-Awaited Transition to NYRx Provides Eight Million Members Expanded Access to Prescription Medications at More Than 5,000 Pharmacies Statewide
How pharmacy deserts are formed
PBMs play a big role in the formation of a pharmacy desert.
Ozempic shortages? Some pharmacists are choosing not to stock the drug at all
Some independent pharmacies are losing money on the pricey — and popular — drug.
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .